Watchlist Price Alert

NGM Biopharmaceuticals In... (NGM)

NASDAQ: NGM · Real-Time Price · USD

1.54

-0.02 (-1.28%)

At close: Apr 03, 2024, 3:59 PM

NGM Biopharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	4.42M	55.33M	77.88M	87.37M	103.54M	108.67M	77.14M	85.59M
Cost of Revenue	2.22M	5.98M	7.9M	163.97M	129.25M	n/a	n/a	n/a
Gross Profit	2.2M	49.35M	69.98M	-76.6M	-25.71M	108.67M	77.14M	85.59M
Operating Income	-146.55M	-166.25M	-120.69M	-103.83M	-49.34M	-4.31M	-17.43M	-8.36M
Interest Income	9.32M	3.71M	420K	1.94M	6.69M	3.62M	2.36M	1.81M
Pretax Income	-142.38M	-162.67M	-120.33M	-102.49M	-42.8M	-493K	-15.22M	-6.42M
Net Income	-142.38M	-159.09M	-113.83M	-93.99M	-28.5M	-493K	-14.16M	-6.92M
Selling & General & Admin	36.73M	40.52M	36.87M	27.23M	23.63M	17.27M	14.83M	11.85M
Research & Development	112.01M	181.07M	161.71M	163.97M	129.25M	95.71M	79.74M	82.11M
Other Expenses	-234K	-132K	-60K	-593K	-147K	199K	-152K	133K
Operating Expenses	148.74M	221.58M	198.58M	191.2M	152.88M	112.98M	94.57M	93.95M
Interest Expense	n/a	3.71M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-1.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	150.96M	221.58M	198.58M	191.2M	152.88M	112.98M	94.57M	93.95M
Income Tax Expense	n/a	-3.58M	-6.51M	-8.49M	-14.3M	3.82M	-1.06M	500K
Shares Outstanding (Basic)	82.5M	79.95M	77.09M	68.48M	50.3M	64.99M	53.65M	53.65M
Shares Outstanding (Diluted)	82.5M	79.95M	77.09M	68.48M	50.3M	64.99M	53.65M	53.65M
EPS (Basic)	-1.73	-1.99	-1.48	-1.37	-0.57	-0.01	-0.26	-0.13
EPS (Diluted)	-1.73	-1.99	-1.48	-1.37	-0.57	-0.01	-0.26	-0.13
EBITDA	-144.33M	-166.25M	-120.69M	-103.83M	-49.34M	2.91M	-10.98M	-4.83M
EBIT	n/a	-158.95M	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	2.22M	4.04M	6.09M	6.55M	7.61M	7.22M	6.44M	3.53M